The long-term trend of the EPS is an important number as it indicates the present value of Avinger. It is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -82.50 % over the last twelve months. The higher the EPS growth rate, the higher the value that is added to shareholders and a good reflection on the performance of the management at Avinger.
Avinger is in the medical devices industry and is in the healthcare sector. The company CEO is Jeffrey M. Soinski. Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease.
Previous Intraday Performance:
The AVGR shares had a previous change of 6.90% which opened at 0.30 and closed at 0.31. It moved to an intraday high of 0.32 and a low of 0.29.
SeekingAlpha: Avinger, Inc. (AVGR) CEO Jeffrey Soinski on Q3 2018 Results – Earnings Call Transcript
Historical Performance:
Over the last five trading days, AVGR shares returned 5.26% and in the past 30 trading days it returned -72.57%. Over three months, it changed -77.86%. In one year it has changed -96.60% and within that year its 52-week high was 10.80 and its 52-week low was 0.27. AVGR stock is 14.81% above its 52 Week Low.
Our calculations result in a 200 day moving average of 1.25 and a 50 day moving average of 0.78. Right now, AVGR stock is trading -75.21% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
SeekingAlpha: Avinger, Inc. (AVGR) CEO Jeffrey Soinski on Q3 2018 Results – Earnings Call Transcript
Liquidity:
The company has a market cap of $7.3m with 23.5m shares outstanding and a float of 23.3m shares. Trading volume was 1,999,500 shares and has experienced an average volume of 1,048,212 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Avinger was -74.78 which ended on 31st of December 2017.
Below was the last reported quarterly earnings per share:
09-30-2018: -0.56
06-30-2018: -0.98
03-31-2018: -5.37
12-31-2017: -9.97
Indicators Also to Watch:
Based on the latest filings, there is 8.90% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.
I calculated the beta to be 1.97
SeekingAlpha: Tracking Wallace Weitz’s Weitz Investment Management Portfolio – Q3 2018 Update
Fundamental Numbers:
Based on last reported financials, the company’s return on equity is 349.40%, return on assets is -199.29%, price-to-sales is 0.87 and price-to-book is 1.75.
Company Score Card:
Results are out of six:
2 : Growth Expectations Result
3 : Financial Safety Result
0 : Past Performance Result
1 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result
Related Tags: AVGR, Avinger, Healthcare, Medical Devices
